These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. J Cutan Pathol; 2023 Aug 27; 50(8):711-716. PubMed ID: 36944579 [Abstract] [Full Text] [Related]
23. Coexistence of CD30-positive anaplastic large cell lymphoma and mycosis fungoides. Kang SK, Chang SE, Choi JH, Sung KJ, Moon KC, Koh JK. Clin Exp Dermatol; 2002 May 27; 27(3):212-5. PubMed ID: 12072011 [Abstract] [Full Text] [Related]
24. Acquisition of CD30 and CD15 accompanied with simultaneous loss of all pan-T-cell antigens in a case of histological transformation of mycosis fungoides with involvement of regional lymph node: an immunophenotypic alteration resembling classical Hodgkin lymphoma. Reddi DM, Sebastian S, Wang E. Am J Dermatopathol; 2015 Mar 27; 37(3):249-53. PubMed ID: 23612034 [Abstract] [Full Text] [Related]
25. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis. Diaz de la Pinta FJ, Machan S, Manso Alonso R, Carvajal N, Nieves Salgado R, Piris MA, Rodriguez-Pinilla SM. Histopathology; 2022 Jan 27; 80(2):446-449. PubMed ID: 34252219 [No Abstract] [Full Text] [Related]
26. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression. Wang RC, Sakata S, Chen BJ, Chang ST, Hsieh PP, Yang CS, Baba S, Takeuchi K, Chuang SS. Pathology; 2018 Dec 27; 50(7):718-724. PubMed ID: 30348505 [Abstract] [Full Text] [Related]
27. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Virchows Arch; 2021 Aug 27; 479(2):377-383. PubMed ID: 33604757 [Abstract] [Full Text] [Related]
28. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Kremer M, Sandherr M, Geist B, Cabras AD, Höfler H, Fend F. Mod Pathol; 2001 Feb 27; 14(2):91-7. PubMed ID: 11235910 [Abstract] [Full Text] [Related]
29. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK, Mullins FM, Kim YH, Kong CS. Cancer; 2008 Oct 25; 114(5):323-32. PubMed ID: 18798522 [Abstract] [Full Text] [Related]
30. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma. Fivenson DP, Hanson CA, Nickoloff BJ. J Am Acad Dermatol; 1994 Nov 25; 31(5 Pt 1):717-23. PubMed ID: 7929915 [Abstract] [Full Text] [Related]
31. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. Wood GS, Bahler DW, Hoppe RT, Warnke RA, Sklar JL, Levy R. J Invest Dermatol; 1993 Sep 25; 101(3):296-300. PubMed ID: 8396607 [Abstract] [Full Text] [Related]
32. Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma. Terada T. Int J Clin Exp Pathol; 2013 Sep 25; 6(4):749-56. PubMed ID: 23573323 [Abstract] [Full Text] [Related]
33. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides. Chandra P, Plaza JA, Zuo Z, Diwan AH, Koeppen H, Duvic M, Medeiros LJ, Prieto VG. Am J Clin Pathol; 2009 Apr 25; 131(4):511-5. PubMed ID: 19289586 [Abstract] [Full Text] [Related]
34. Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma. Akilov OE, Pillai RK, Grandinetti LM, Kant JA, Geskin L. Arch Dermatol; 2011 Aug 25; 147(8):943-7. PubMed ID: 21844453 [Abstract] [Full Text] [Related]
35. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, Burg G, Kadin ME. J Cutan Pathol; 2002 May 25; 29(5):295-300. PubMed ID: 12100631 [Abstract] [Full Text] [Related]
36. The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases. Kapur S, Tiemann M, Menke MA, Schubert C, Parwaresch R. Indian J Med Res; 2005 Jan 25; 121(1):46-54. PubMed ID: 15713979 [Abstract] [Full Text] [Related]
37. Cutaneous composite lymphoma of mycosis fungoides and Hodgkin lymphoma: Response to sequential therapy. Chen Y, Nong L, Li X, Wang Y. J Cutan Pathol; 2020 Sep 25; 47(9):829-833. PubMed ID: 32285466 [Abstract] [Full Text] [Related]
39. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites. Zhang Y, Chen M, Yu Y, Liu X, Liu W, Jiang L, Zhang W. J Cutan Pathol; 2022 Feb 25; 49(2):187-190. PubMed ID: 34622970 [Abstract] [Full Text] [Related]
40. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma. LeBlanc RE, Lefterova MI, Suarez CJ, Tavallaee M, Kim YH, Schrijver I, Kim J, Gratzinger D. Hum Pathol; 2015 Sep 25; 46(9):1382-9. PubMed ID: 26193796 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]